Source: Eur Respir J, 56 (2) 2002411; 10.1183/13993003.02411-2020
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Laia Fernández-Barat, Ruben López-Aladid, Antoni Torres. The value of serology testing to manage SARS-CoV-2 infections. Eur Respir J, 56 (2) 2002411; 10.1183/13993003.02411-2020

Member's Comments

No comment yet.

Related content which might interest you: IGRA testing to diagnose TB disease and infection. What is new in clinical practice and for programmatic management Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 The use of interferon-γ-based blood tests for the detection of latent tuberculosis infection Source: Eur Respir J 2006; 28: 1-3 Year: 2006 Performance of a new direct immunofluorescence test for detection of human metapneumovirus in the routine diagnostic laboratory Source: Annual Congress 2007 - Immunological function in viral and nonviral pathogens Year: 2007 HIV infection and diagnostic tests for pleural tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 360s Year: 2001 Value of QFT-IT test for diagnosing latent TB infection in HIV+ Source: ISSN=ISSN 1810-6838, ISBN=, page=284 Year: 2007 The specificity of interferon-γ-based blood tests in the identification of latent tuberculosis infection Source: Eur Respir J 2006; 28: 1283 Year: 2006 Comparison of the tuberculin skin test and the ELISPOT blood test for the diagnosis of latent tuberculosis infection in pre-transplant dialysis patients Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI Year: 2005 Utility of tuberculin and anergy skin testing in predicting TB infection in HIV infected children in Constantza county Source: Eur Respir J 2003; 22: Suppl. 45, 157s Year: 2003 Sensitivity of C-Tb: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection Source: Eur Respir J 2016; 47: 919-928 Year: 2016 The set of immunological tests for detection of active tuberculosis in children with latent infection Source: International Congress 2019 – Paediatric tuberculosis Year: 2019 Contribution of the T-SPOT.TB assay for detection of latent tuberculous infection (LTBI) in contact tracing procedures Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection Year: 2006 Advances in the diagnosis of mycobacteria infections and challenges of drug susceptibility testing Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Year: 2019 Respiratory viral point of care testing (POCT) allows improved infection control and bed management  during an influenza outbreak Source: International Congress 2018 – Clinical challenges in respiratory infection Year: 2018 Comparison of a T-cell-based assay with tuberculin skin testing (TST) for diagnosis of latent tuberculosis infection (LTBI) in contact-tracing procedures Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI Year: 2005 Quantiferon and tuberculin skin test for detection of tuberculosis infection in immunocompromised patients Source: Annual Congress 2010 - Clinical tuberculosis Year: 2010 Performance of blood tests for the diagnosis of latent tuberculosis infection in children Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease Year: 2008 IGRA testing correlation with clinical and laboratory parameters in patients with tuberculosis Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 The need of a minimal set of tests to identify mycobacterium species isolated from lower tract respiratory infections Source: Eur Respir J 2007; 30: Suppl. 51, 662s Year: 2007